Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott AKI diagnosis kit receives CE mark

Abbott AKI diagnosis kit receives CE mark

8th October 2009

Abbott has revealed that its acute kidney injury (AKI) test, which aids in the early diagnosis of the condition, has been granted the CE mark.

The equipment works by testing an integral protein in urine – neutrophil gelatinase-associated lipocalin (NGAL) – an early marker or indicator for patients with, or at risk of, AKI.

It enables NGAL to be recognised in as little as two hours, rather than a matter of days, allowing for the earlier detection of the condition, which, if left untreated, can lead to kidney failure.

Patrick Murray, professor at the University College Dublin and Mater Misericordiae University Hospital, said: “Earlier and more accurate differential diagnosis of evolving AKI could result in quicker changes in patient management to make potentially life-saving therapeutic interventions and stop harmful progression.”

In other recent Abbott news, the firm revealed that it has cut its reliance upon fossil fuels, leading to a 35 per cent reduction in its use of coal and oil within the last three years.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.